Cite
HARVARD Citation
Nemunaitis, J. et al. (2015). TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].